| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72542-193-01 | 72542-193 | HUMAN PRESCRIPTION DRUG | MIPLYFFA | arimoclomol citrate | CAPSULE | ORAL | 20240920 | N/A | NDA | NDA214927 | Acer Therapeutics Inc. | ARIMOCLOMOL CITRATE | 93 mg/1 | 1 BOTTLE in 1 CARTON (72542-193-01) / 90 CAPSULE in 1 BOTTLE |
| 72542-147-01 | 72542-147 | HUMAN PRESCRIPTION DRUG | MIPLYFFA | arimoclomol citrate | CAPSULE | ORAL | 20240920 | N/A | NDA | NDA214927 | Acer Therapeutics Inc. | ARIMOCLOMOL CITRATE | 47 mg/1 | 1 BOTTLE in 1 CARTON (72542-147-01) / 90 CAPSULE in 1 BOTTLE |
| 72542-124-01 | 72542-124 | HUMAN PRESCRIPTION DRUG | MIPLYFFA | arimoclomol citrate | CAPSULE | ORAL | 20240920 | N/A | NDA | NDA214927 | Acer Therapeutics Inc. | ARIMOCLOMOL CITRATE | 124 mg/1 | 1 BOTTLE in 1 CARTON (72542-124-01) / 90 CAPSULE in 1 BOTTLE |
| 72542-162-01 | 72542-162 | HUMAN PRESCRIPTION DRUG | MIPLYFFA | arimoclomol citrate | CAPSULE | ORAL | 20240920 | N/A | NDA | NDA214927 | Acer Therapeutics Inc. | ARIMOCLOMOL CITRATE | 62 mg/1 | 1 BOTTLE in 1 CARTON (72542-162-01) / 90 CAPSULE in 1 BOTTLE |